Clinical Report: Systematic Review of Hypothalamic Deep Brain Stimulation Techniques

Overview

This systematic review analyzed 34 studies involving 412 patients undergoing hypothalamic deep brain stimulation (DBS) for various neuropsychiatric and neurological conditions. The most common indications were refractory chronic cluster headaches and aggressive behavior, with the posterior hypothalamus being the predominant DBS target.

Background

The hypothalamus, a small but complex brain region, regulates critical neuroendocrine, behavioral, and autonomic functions. It integrates signals from multiple brain areas and communicates with the pituitary gland via the hypothalamic–pituitary–adrenal axis. Since the first hypothalamic DBS application in 1970 for aggressive behavior, stereotactic hypothalamic DBS has been explored for treating diverse psychological and neurological disorders. This review systematically evaluates the functional organization of the hypothalamus, DBS targets, and clinical outcomes.

Data Highlights

Key Findings

• Of 34 studies, 70.6% originated from Europe, with the remainder from South and North America.
• 412 patients underwent hypothalamic DBS, predominantly adults, with a male majority (63.6%).
• Refractory chronic cluster headache was the most frequent indication (57.8%), followed by aggressive behavior (24.3%).
• The posterior hypothalamus was the most common DBS target (44.1% of studies), primarily for cluster headaches and aggressive behavior.
• Mean disease duration varied widely, with cluster headache patients having the longest average duration (~20 years).
• Other indications included mild Alzheimer’s disease, trigeminal neuralgia in multiple sclerosis, Prader-Willi syndrome, and atypical facial pain.

Clinical Implications

Hypothalamic DBS shows promise for refractory neuropsychiatric conditions, especially chronic cluster headaches and aggressive behavior. Targeting the posterior hypothalamus appears most effective for these indications. Clinicians should consider patient-specific factors such as disease duration and symptomatology when selecting candidates and DBS targets.

Conclusion

This systematic review highlights the evolving role of hypothalamic DBS in managing refractory neurological and behavioral disorders, emphasizing the posterior hypothalamus as a key target. Further research is warranted to optimize patient selection and stimulation parameters.

References

1. Sano et al. 1970 -- First hypothalamic DBS application for aggressive behavior
2. PRISMA Guidelines 2023 -- Systematic Review Methodology